Aortopulmonary Septal Defect

Subscribe to Selected New Research on Aortopulmonary Septal Defect

5 relevant articles (0 outcomes, 0 trials/studies) found for this Disease

Description: A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).

Also Known As:

Aorticopulmonary Septal Defect; Aorticopulmonary Septal Defects; Aortopulmonary Septal Defects; Septal Defect, Aorticopulmonary; Septal Defect, Aortopulmonary; Septal Defects, Aorticopulmonary; Septal Defects, Aortopulmonary

Disease Context: Research Results

Cardiovascular Diseases: 18443

Heart Diseases: 12330

Congenital Heart Defects: 685

Heart Septal Defects: 4

Aortopulmonary Septal Defect: 5

Persistent Truncus Arteriosus: 23

Cardiovascular Abnormalities: 167

Congenital Heart Defects: 685

Heart Septal Defects: 4

Aortopulmonary Septal Defect: 5

Persistent Truncus Arteriosus: 23

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 420

Congenital Abnormalities: 9307

Cardiovascular Abnormalities: 167

Congenital Heart Defects: 685

Heart Septal Defects: 4

Aortopulmonary Septal Defect: 5

Persistent Truncus Arteriosus: 23

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Aortopulmonary Septal Defect:

1.	Coenzyme A (CoA)IBA 04/01/1997 - "Two infants with aorticopulmonary septal defect (APSD) and coarctation of the aorta (CoA) underwent primary surgical repair and their aortic arches were reconstructed in a manner of end-to-end anastomosis" Get all the results and reference details, order at left...
2.	nitrofen (TOK)IBA 02/01/2008 - "In addition, the GATA4/GATA6 double heterozygous mutant embryo model displayed a spectrum of cardiovascular malformations similar to those seen in human CDH and nitrofen-induced animal models, including ventricular and aortopulmonary septal defects and thin ventricular myocardium" Get all the results and reference details, order at left...
2 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Transplants (Transplant) 08/01/1994 - "Aortopulmonary septal defect, interruption of the aortic arch, and anomalous origin of the right pulmonary artery from the aorta comprised a challenging constellation of defects in a 13-day-old neonate, who underwent complete repair without homograft tissue or synthetic graft" Get all the results and reference details, order at left...
2.	Homologous Transplantation (Allograft) 08/01/1994 - "Aortopulmonary septal defect, interruption of the aortic arch, and anomalous origin of the right pulmonary artery from the aorta comprised a challenging constellation of defects in a 13-day-old neonate, who underwent complete repair without homograft tissue or synthetic graft" Get all the results and reference details, order at left...
3.	Sutures (Suture) 09/01/1981 - "Operative techniques included ligation, direct suture, and patch closure of the aortopulmonary septal defect" Get all the results and reference details, order at left...
4.	Ligation 09/01/1981 - "Operative techniques included ligation, direct suture, and patch closure of the aortopulmonary septal defect" Get all the results and reference details, order at left...
5.	Cardiopulmonary Bypass (Heart-Lung Bypass) 10/01/1991 - "In a 20-days old girl, aortopulmonary septal defect (total defect type) was closed by transaortic patch repair with cardiopulmonary bypass (CPB)" Get all the results and reference details, order at left...
5 Therapies and Procedures and 3 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>